Page last updated: 2024-08-17

apomorphine and 4-aminopyridine

apomorphine has been researched along with 4-aminopyridine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Groves, PM; Sawyer, SF; Tepper, JM; Young, SJ1
Artaud, F; Borrelli, E; Chéramy, A; Glowinski, J; Godeheu, G; L'hirondel, M; Saiardi, A1
Faraji, A; Fraidouni, N; Hadibeygi, E; Haghdoost-Yazdi, H; Movahedi, M; Vaezi, F1
Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Mahmudi, M; Piri, H1
Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Najafipour, R; Piri, H1

Other Studies

6 other study(ies) available for apomorphine and 4-aminopyridine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of potassium channel blockers.
    Brain research, 1986, Mar-05, Volume: 367, Issue:1-2

    Topics: 4-Aminopyridine; Aminopyridines; Animals; Apomorphine; Corpus Striatum; Electric Stimulation; Ion Channels; Male; Neural Inhibition; Potassium; Rats; Rats, Inbred Strains; Receptors, Dopamine; Tetraethylammonium; Tetraethylammonium Compounds

1986
Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
    Brain research, 1998, May-11, Volume: 792, Issue:2

    Topics: 4-Aminopyridine; Amphetamine; Animals; Apomorphine; Autoreceptors; Benzopyrans; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoresceins; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Neural Inhibition; Oxazines; Potassium Chloride; Presynaptic Terminals; Quinpirole; Receptors, Dopamine D2; Synaptosomes; Tritium

1998
Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.
    Behavioural brain research, 2011, Sep-30, Volume: 223, Issue:1

    Topics: 4-Aminopyridine; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Drug Interactions; Male; Medial Forebrain Bundle; Microinjections; Oxidopamine; Parkinson Disease, Secondary; Potassium Channel Blockers; Rats; Rats, Wistar; Tetraethylammonium

2011
Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
    Neurological research, 2016, Volume: 38, Issue:4

    Topics: 4-Aminopyridine; Adrenergic Agents; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Functional Laterality; Male; Mental Disorders; Motor Activity; Oxidopamine; Parkinsonian Disorders; Postural Balance; Potassium Channel Blockers; Rats; Rats, Wistar; Tetraethylammonium; Thiazolidinediones

2016
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
    Neurosciences (Riyadh, Saudi Arabia), 2017, Volume: 22, Issue:1

    Topics: 4-Aminopyridine; Animals; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Synergism; Male; Malondialdehyde; Medial Forebrain Bundle; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Potassium Channel Blockers; Rats; Rotarod Performance Test; Tetraethylammonium

2017